News
This week: New press draws attention to the dangers of poorly regulated medspas
Elle published an exposé about bad actors and loose regulation in the medical spa industry.
[...]August 18, 2025: PSM, ADAP ask New York’s Board of Pharmacy to act in alleged fake medicine case
On August 7, the Partnership for Safe Medicines and ADAP Advocacy Association filed a complaint asking the New York State Board of Pharmacy to take regulatory action against a pharmacy that allegedly sold counterfeit HIV medicine to a Queens, New York patient.
[...]Public health groups raise alarm about fake HIV medicines in New York
PSM and ADAP Advocacy Association filed an official complaint with the State of New York regarding allegations that City Plus Care Pharmacy Inc. dispensed counterfeit HIV medication to a patient in Queens, New York.
[...]August 11, 2025: The FDA voices concern about sites that supply compounding ingredients
Statistics in the agency’s Report on the State of Pharmaceutical Quality show that active pharmaceutical ingredient (API) sites that solely supply compounding pharmacies are disproportionately high risk.
[...]PSM signs letter of support for changes to Mississippi’s compounding pharmacy guidelines
The proposed updates aim to help address safety concerns created by pharmacies reselling compounded sterile drugs purchased from outsourcing facilities.
[...]August 4, 2025: Pennsylvania pharmacy owner indicted and 14 licenses revoked in Ohio
The Pennsylvania Attorney General filed charges against a pharmacy owner and the Ohio Board of Pharmacy revoked licenses to protect patients.
[...]July 28, 2025: Suspicious shipments of API continue to be sent to buyers in the U.S.
The newest Fishy Freight report continued to find suspect API shipped into the U.S. while a report from the United Nations’ Office of Drug Crime highlighted the dangers of contaminated and counterfeit medicines made with diethylene glycol and ethylene glycol.
[...]Prescription Drug Freight Fraud Report, July 2025
What if your tirzepatide shipment came from a Brazilian beauty clinic? Or a vial of semaglutide was manufactured, supposedly, at a Costco in Toronto? In April and May 2025, dozens of shipments of semaglutide, tirzepatide, apixaban, and antibiotics entered the U.S. from facilities that aren’t in the FDA’s drug manufacturing database. These aren’t low-volume personal-use…
[...]Final publication of guidelines for online pharmacy-to-pharmacy medicine marketplaces
We’ve published the final document of best practices for online pharmacy-to-pharmacy marketplaces.
[...]Partnership for Safe Medicines Applauds Reintroduction of the Cooper Davis Devin Norring Act
The Partnership for Safe Medicines (PSM) today announced its strong support for the reintroduction of the Cooper Davis Devin Norring Act, a bipartisan effort aimed at curbing the online sale of deadly counterfeit and illicit drugs.
[...]